cas 16084-57-4|| where to buy 3-Azabicyclo[3.2.0]heptane hydrochloride

Nom du produit:3-Azabicyclo[3.2.0]heptane hydrochloride

IUPAC Name:3-azabicyclo[3.2.0]heptane hydrochloride

Unité d'emballage	Stock disponible	Prix($)
CM107216-100mg	in stock	ȎȀȀ
CM107216-250mg	in stock	Ţƞǯ
CM107216-10g	in stock	ƄȀƞǯ

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 16084-57-4 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:16084-57-4; Formule moléculaire:C6H12ClN; Point de fusion:-; Code SMILES:[H]Cl.C12CNCC1CC2; Densité:

: Numéro de catalogue:CM107216; Poids moléculaire:133.62; Point d'ébullition:; N° Mdl:; Stockage:

: Pyrrolidines; Pyrrolidine, also known as tetrahydropyrrole, is a saturated five-membered heterocyclic ring, which is miscible with water. Pyrrolidine exists in many alkaloids and drug molecules, such as kappa opioids, antagonists of dopamine D4 receptors, and HIV reverse transcriptase inhibitors.

: Cyclobutanes; The molecular structure of cyclobutane has four carbon atoms, and its four carbon atoms are not in the same plane, which is the folded conformation of cyclobutane. Cyclobutane itself is not of commercial or biological interest, but more complex derivatives are important in biology and biotechnology. Currently, nine FDA-approved drugs contain the cyclobutane structure. From the perspective of therapeutic areas, cyclobutyl drugs are mainly distributed in popular areas such as tumors, neurological diseases, infectious diseases, endocrine and metabolic diseases.

: Alicyclic Heterocycles; When the ends of the chains are joined together into a ring, cyclic compounds result; such substances often are referred to as carbocyclic or alicyclic compounds. Substitution of one or more of the ring carbon atoms in the molecules of a carbocyclic compound with a heteroatom gives a heterocyclic compound.